Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Management
Scientific Advisory Board
Corporate Governance
Investors
Investor Welcome
Company Fact Sheet
ASX Announcements
Neuroprotection Program
Cardioprotection Program
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Key Dates
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Extraordinary General Meeting
Past Shareholder Meetings
News & Insights
Presentations & Interviews
Media
Newsletters
Publications
Contact Us
Contact Us
Working at Nyrada
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Welcome
Company Fact Sheet
ASX Announcements
Neuroprotection Program
Cardioprotection Program
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Key Dates
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Extraordinary General Meeting
Past Shareholder Meetings
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
28-Oct-2024
Proposed issue of securities - NYR
28-Oct-2024
Investor Presentation
28-Oct-2024
Nyrada Successfully Raises $3.36 Million via Placement
24-Oct-2024
Trading Halt
24-Oct-2024
Quarterly Activities Report and Appendix 4C
23-Oct-2024
Supplementary NYR-BI03 Study Confirm Strong Cardioprotection
16-Oct-2024
NYR Completes Safety Studies Ahead of Phase I Clinical Trial
7-Oct-2024
Brain Injury Program GLP Studies Further Update 6
4-Oct-2024
Investor Presentation
1-Oct-2024
Drug Candidate Demonstrates Significant Cardioprotection
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Next
